Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/III randomized double-blind trial of DTaP-sIPV/Hib vaccine in healthy 2-month-old infants
CTR20253865Phase 3Active
- Sponsor
- Beijing Minhai Biological
- Start
- Oct 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria, tetanus, acellular pertussis, Sabin inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine, adsorbed in pertussis, diphtheria, Tetanus, poliomyelitis, Haemophilus influenzae type b invasive infection (Hib), sponsored by Beijing Minhai Biological. Started Oct 2025; status: active.
02
Drugs
diphtheria, tetanus, acellular pertussis, Sabin inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine, adsorbed
03
Conditions
pertussisdiphtheriaTetanuspoliomyelitisHaemophilus influenzae type b invasive infection (Hib)
Beyond the preview
Go deeper on CTR20253865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253865.